Mednet Logo
CommunityMedical Oncology

How do you approach management of limited stage SCLC in a patient with idiopathic pulmonary fibrosis?

Community PollStarted

How do you approach management of limited stage SCLC in a patient with idiopathic pulmonary fibrosis?

126 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Louisville
Answered on

I've seen a few patients with IPF and small cell. The concern is always that these patients have an underlying pro-inflammatory lung condition that makes them more prone to pneumonitis. My preference in this specific group is to give and complete chemotherapy first and then restage the patient. Sinc...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Answered on

Depends on the severity of PF. This is a multidisciplinary (and patient) decision. We tend to treat with concurrent chemoradiation if IPF is mild or even moderate and stable. We have also treated some patients with mild but progressive IPF with CRT along with antiproliferative/antifibrotic agents fo...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Quillen VA Medical Center
Answered on

I’ve never seen a case with LS-SCLC and pulmonary fibrosis. Without a CT, or PFT’s, I would tend to treat with 4 cycles Carbo/Etoposide. If there were no N+ nodes to start, I would hypofx 45 Gy in 3 weeks or 60 in 4 to the residual lesion. If N2 positive, concurrent 45 Gy bid cycle 3 concurrent.


Upd...

Join for free or sign in to see the full answer